5 results
8-K
EX-99.1
Core Laboratories Inc.
24 Apr 24
First Quarter Revenue of $129.6 Million, Up Modestly Sequentially and Year-over-year
4:35pm
capabilities in the Middle East and other international markets prior to and during the global pandemic are now delivering results, as long-delayed
DEF 14A
Core Laboratories Inc.
18 Mar 24
Definitive proxy
6:07pm
% during the global pandemic. These temporary reductions were effective from April 2020 through December 2021.
The First CEO determined that bonuses
10-K
2023 FY
Core Laboratories Inc.
14 Feb 24
Annual report
7:08pm
results.
A global or domestic health crisis such as the COVID-19 pandemic may significantly reduce demand for our services, and may have a material … . Government reaction to a pandemic and restrictions and limitations applied by governments, continued widespread growth in infections, travel
8-K
EX-99.1
Core Laboratories Inc.
31 Jan 24
Fourth Quarter Revenue of $128.2 Million, Up 2% Sequentially
5:16pm
, Core’s investments to expand capabilities in the Middle East and Latin American markets prior to the global pandemic are now coming to fruition
10-Q
2023 Q2
Core Laboratories Inc.
27 Jul 23
Quarterly report
5:05pm
products were disrupted during the COVID-19 global pandemic, and lead times continue to be much longer than average lead times prior to the pandemic
- Prev
- 1
- Next